One-pot MCDA-CRISPR-Cas-based detection platform for point-of-care testing of severe acute respiratory syndrome coronavirus 2
2024

New One-Pot Test for COVID-19 Detection

Sample size: 70 publication 10 minutes Evidence: high

Author Information

Author(s): Wang Xiaoxia, Yang Rui, Tang Tian, Zhou Yuzhen, Chen Heng, Jiang Yihao, Zhang Shirong, Qin Sihan, Wang Meijuan, Wang Chuan

Primary Institution: West China School of Public Health and West China Fourth Hospital, Sichuan University

Hypothesis

Can a one-pot MCDA-CRISPR-Cas method improve the detection of SARS-CoV-2?

Conclusion

The MCTOP method is a rapid, convenient, and highly sensitive tool for detecting SARS-CoV-2.

Supporting Evidence

  • The MCTOP method showed 100% specificity and high sensitivity in detecting SARS-CoV-2.
  • The detection limit of the method was 10 copies of target sequences.
  • Results can be visualized using real-time fluorescence instruments or lateral flow biosensors.
  • The method is suitable for point-of-care testing in remote areas.

Takeaway

Scientists created a new test that can quickly find COVID-19 using a simple method that doesn't need a lot of fancy equipment.

Methodology

The study developed a one-pot method combining multiple cross displacement amplification (MCDA) and CRISPR-Cas12b for SARS-CoV-2 detection.

Potential Biases

Potential for cross-contamination during testing due to aerosol generation.

Limitations

The method is qualitative and does not provide statistical validation metrics like mean values or standard deviation.

Participant Demographics

70 pharyngeal swab samples, including 50 positive and 20 negative for SARS-CoV-2.

Digital Object Identifier (DOI)

10.3389/fmicb.2024.1503356

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication